Henry Schein Valuation Overview

HSIC -- USA Stock  

USD 84.75  0.80  0.95%

Henry Schein retains regular Real Value of $131.2585 per share. The prevalent price of the corporation is $84.75. At this time the corporation appears to be under valued. Macroaxis calculates value of Henry Schein from evaluating the corporation fundamentals such as Current Valuation of 15.22B, Return On Asset of 7.53% and Return On Equity of 13.21% as well as inspecting its technical indicators and Probability Of Bankruptcy. In general, we encourage to acquire undervalued assets and to sell overvalued assets since at some point stocks prices and their ongoing real values will come together.
Valuation Drivers Correlation
Click cells to compare fundamentals   View All Correlations
Henry Schein Valuation Data Drivers
Net Income Per Employee    Enterprise Value    Market Capitalization    
Henry Schein Market Cap
Henry Schein is rated below average in market capitalization category among related companies. Market capitalization of Medical Distribution industry is currently estimated at about 222.66 Billion. Henry Schein holds roughly 12.85 Billion in market capitalization claiming about 6% of all equities under Medical Distribution industry.
Capitalization  Workforce  Total debt  Revenue  Valuation
Horizon     30 Days    Login   to change
Henry Schein is rated below average in beta category among related companies. It is rated # 5 in price to sales category among related companies fabricating about  0.93  of Price to Sales per Beta. The ratio of Beta to Price to Sales for Henry Schein is roughly  1.08 

Current Market Valuation

Henry Schein Valuation Boundaries

Under Valued
October 16, 2018
Market Value
Real Value
Target Odds
Henry Schein is not too risky asset. Calculation of real value of Henry Schein is based on 1 month time horizon. Increasing Henry Schein time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.

Valuation Basics

Henry Schein Enterprise Value Fundamentals

Quick Ratio0.53
Earnings Quarterly Growth3.80%
Revenue Growth8.70%
Payout Ratio0.00%
Enterprise Value To Ebitda13.82
Earnings Growth7.00%
Enterprise Value To Revenue1.17
Please also check Risk vs Return Analysis. Please also try Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Search macroaxis.com